申请人:Otsuka Pharmaceutical Factory, Inc.
公开号:US05527786A1
公开(公告)日:1996-06-18
The present invention provides a phosphonic diester derivative of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are the same or different and they each represent a hydrogen atom, a lower alkyl group, a halogen atom, a cyano group, a hydroxyl group, or a lower alkoxy group optionally having a halogen atom, a phenyl group or a hydroxypiperidino group as a substituent; R.sup.4 represents a hydrogen atom, a lower alkoxy group, a halogen atom, or a lower alkyl group optionally having a halogen atom or a cyano group as a substituent; and R.sup.5 and R.sup.6 are the same or different and they each represent a hydrogen atom or a lower alkyl group. The derivative of the present invention has excellent hypolipidemic, vasodepressor and hypoglycemic activities and is useful as therapeutic and preventive agents for hyperlipidemic diseases, hypertension and diabetes.
本发明提供了一个磷酸二酯衍生物的公式:##STR1##
其中,R.sup.1,R.sup.2和R.sup.3相同或不同,它们分别代表氢原子,较低的烷基,卤素原子,氰基,羟基或较低的烷氧基,可选地具有卤素原子,苯基或羟基哌啶基作为取代基; R.sup.4代表氢原子,较低的烷氧基,卤素原子或较低的烷基,可选地具有卤素原子或氰基作为取代基; R.sup.5和R.sup.6相同或不同,它们分别代表氢原子或较低的烷基。本发明的衍生物具有出色的降脂,降压和降糖活性,并且可用作治疗和预防高脂血症,高血压和糖尿病的药物。